Shopping Cart
- Remove All
- Your shopping cart is currently empty
EHT 5372 is a potent and selective inhibitor of DYRK's family kinases. EHT 5372 shows IC 50 s of 0.22, 0.28, 10.8, 93.2, 22.8, 88.8, 59.0, 7.44, 221 nM for DYRK1A, DYRK1B, DYRK2, DYRK3, CLK1, CLK2, CLK4, GSK-3α, GSK-3β.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,620 | 8-10 weeks | |
50 mg | $2,110 | 8-10 weeks |
Description | EHT 5372 is a potent and selective inhibitor of DYRK's family kinases. EHT 5372 shows IC 50 s of 0.22, 0.28, 10.8, 93.2, 22.8, 88.8, 59.0, 7.44, 221 nM for DYRK1A, DYRK1B, DYRK2, DYRK3, CLK1, CLK2, CLK4, GSK-3α, GSK-3β. |
In vitro | EHT 5372 (0.1-10 μM; 24 hours) dose-dependently reduces pS396-Tau levels with an IC50 of 1.7 μM, maintaining cell viability over 87% in all conditions. It inhibits Tau phosphorylation by DYRK1A (0.01-1 μM) and reduces Aβ production with an IC50 of 1.06 μM. [1]. Cell Line: HEK293 cells. Concentration: 0.1, 0.5, 1, 5, 10 μM; Incubation Time: 24 hours. Results: Cell viability remained over 87%. Concentration: 0.01, 0.03, 0.1, 0.3, 1 μM. Result: Potently inhibited Tau phosphorylation at pS396 dose-dependently. |
Molecular Weight | 404.27 |
Formula | C17H11Cl2N5OS |
Cas No. | 1425945-63-6 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.